[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Krystal Biotech, Inc. Common Stock (KRYS) Krystal Biotech receives FDA Platform Technology Designation, boosting confidence in its gene therapy platform. However, negative sentiment and price target cuts continue to weigh on the stock. ### About Krystal Biotech, Inc. Common Stock Krystal Biotech, Inc. Common Stock (KRYS) is a biotechnology company specializing in gene therapy for dermatological diseases. Krystal Biotech, Inc. Common Stock uses the ticker $KRYS for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$krys/insights) - Krystal Biotech, Inc. Common Stock (KRYS) social dominance is up XXXXX% from the previous month. ### Price: $XXXXXX [#](/topic/$krys/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$krys/time-series/close.tsv) The stock price is facing downward pressure due to negative sentiment and price target reductions, but a short-term positive trend suggests a possible price increase. The market is overall slightly positive, suggesting a hold on the stock. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXX% | XXXX% | **1-Year High**: $XXXXXX on 2024-11-08 **1-Year Low**: $XXXXXX on 2025-05-28 ### AltRank: XXX [#](/topic/$krys/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$krys/time-series/alt_rank.tsv) Krystal Biotech, Inc. Common Stock (KRYS) is currently AltRank #878 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXXXX +446 **1 Month**: XXX +481 **6 Months**: XXX +406 **1 Year**: XXX +473 **1-Year High**: XXXXX on 2025-09-08 **1-Year Low**: XX on 2025-01-11 ### Galaxy Score: XXXXX [#](/topic/$krys/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$krys/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX -X **1 Month**: XX -XX **6 Months**: XX -XX **1 Year**: XX -XX **1-Year High**: XX on 2025-03-03 **1-Year Low**: XX on 2024-10-27 ### Engagements: XXX [#](/topic/$krys/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$krys/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXXXX **1 Week**: XXXXX -XX% **1 Month**: XXXXXX -XX% **6 Months**: XXXXXXXXX -XX% **1 Year**: XXXXXXXXX -XX% **1-Year High**: XXXXXXX on 2025-02-19 **1-Year Low**: XXX on 2025-10-19 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: XX [#](/topic/$krys/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$krys/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX -XXXX% **1 Year**: XXXXX +92% **1-Year High**: XXX on 2025-06-30 **1-Year Low**: XX on 2025-09-07 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: XX [#](/topic/$krys/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$krys/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Krystal Biotech, Inc. Common Stock (KRYS) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX +91% **1 Year**: XXXXX +101% **1-Year High**: XXX on 2025-06-30 **1-Year Low**: X on 2025-09-07 The most influential creators that mention Krystal Biotech, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XXX | | [@Andre_AGTC](/creator/twitter/Andre_AGTC) | X | XXXXX | X | XX | | [@linhnguyen64143](/creator/twitter/linhnguyen64143) | X | XX | X | X | | [@seedy19tron](/creator/twitter/seedy19tron) | X | XXXXX | X | X | [View More](/list/creators/$krys/100) ### Sentiment: XX% [#](/topic/$krys/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$krys/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% -XX% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-10-20 **1-Year Low**: XX% on 2025-02-01 **Most Supportive Themes** - **Gene Therapy Advancements:** (30%) Positive Phase X results and ongoing clinical trials are generating optimism. - **Mentions in Investment Discussions:** (25%) Krystal Biotech is being included in discussions about future investment opportunities and potential growth sectors. **Most Critical Themes** - **Negative Sentiment and Price Target Cuts:** (45%) Downward pressure on the stock price is attributed to negative sentiment and reductions in price targets by analysts. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XX | X% | XXX | XX% | X | X% | | | | | | | | | | Total | XX | X% | XXX | XX% | X | X% | ### Social Dominance: XXXXXXX% [#](/topic/$krys/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$krys/time-series/social_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXXX% +0.0008999999999999998% **1 Month**: XXXXXX% +0.0012% **6 Months**: XXXXXX% -XXXXXX% **1 Year**: XXXXXX% -XXXXX% **1-Year High**: XXXXX% on 2024-11-04 **1-Year Low**: XXXXXX% on 2025-09-07 ### Market Dominance: XXXXXXX% [#](/topic/$krys/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$krys/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2024-11-08 **1-Year Low**: XXXXXXX% on 2025-10-19 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$krys/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$krys/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$5.80% **1 Month**: $XXXXXXXXXXXXX +$16% **6 Months**: $XXXXXXXXXXXXX +$13% **1 Year**: $XXXXXXXXXXXXX +$7% **1-Year High**: $XXXXXXXXXXXXX on 2024-11-08 **1-Year Low**: $XXXXXXXXXXXXX on 2025-05-28 **Top assets mentioned** In the posts about Krystal Biotech, Inc. Common Stock in the last XX hours [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [AAR Corp. (AIR)](/topic/$air) [Century Aluminum Co (CENX)](/topic/$cenx) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Astera Labs, Inc. Common Stock (ALAB)](/topic/$alab) [SoFi Technologies, Inc. Common Stock (SOFI)](/topic/sofi-technologies) [Tesla, Inc. (TSLA)](/topic/tesla) [AbbVie Inc (ABBV)](/topic/$abbv) **Top topics mentioned** In the posts about Krystal Biotech, Inc. Common Stock in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [sentiment](/topic/sentiment), [stocks technology](/topic/stocks-technology), [stocks basic materials](/topic/stocks-basic-materials), [stocks financial services](/topic/stocks-financial-services), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$mdgl](/topic/$mdgl), [coins defi](/topic/coins-defi), [pricing](/topic/pricing), [$ions](/topic/$ions), [stocks](/topic/stocks), [$air](/topic/$air), [$cenx](/topic/$cenx), [$cldx](/topic/$cldx), [$alab](/topic/$alab), [sofi technologies](/topic/sofi-technologies), [coins solana ecosystem](/topic/coins-solana-ecosystem), [tesla](/topic/tesla), [$abbv](/topic/$abbv), [$xene](/topic/$xene), [$bbio](/topic/$bbio), [coins bsc](/topic/coins-bsc), [henry](/topic/henry), [william](/topic/william), [$halo](/topic/$halo), [$insm](/topic/$insm), [$inbs](/topic/$inbs), [$itci](/topic/$itci), [$iti](/topic/$iti), [$jspr](/topic/$jspr), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$brkb](/topic/$brkb), [$on](/topic/$on), [$nvts](/topic/$nvts), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [west pharmaceutical services inc](/topic/west-pharmaceutical-services-inc), [ge healthcare](/topic/ge-healthcare), [$akro](/topic/$akro), [$pcvx](/topic/$pcvx), [$ptct](/topic/$ptct), [$mrus](/topic/$mrus), [$rytm](/topic/$rytm), [$vrna](/topic/$vrna), [$axsm](/topic/$axsm), [$dave](/topic/$dave), [$mmyt](/topic/$mmyt), [$abeo](/topic/$abeo), [$rares](/topic/$rares), [$rvmd](/topic/$rvmd), [$crsp](/topic/$crsp), [$beam](/topic/$beam), [$celu](/topic/$celu), [$clrb](/topic/$clrb), [$cadl](/topic/$cadl), [$spro](/topic/$spro), [$apre](/topic/$apre), [$pgy](/topic/$pgy), [$qnrx](/topic/$qnrx), [$1b](/topic/$1b), [6 months](/topic/6-months), [monaco](/topic/monaco), [applied](/topic/applied), [deb](/topic/deb), [over the](/topic/over-the), [confirms](/topic/confirms), [vivo](/topic/vivo), [$rrhby](/topic/$rrhby), [$nvs](/topic/$nvs), [$bmrn](/topic/$bmrn), [$amrx](/topic/$amrx), [$ci](/topic/$ci), [$cort](/topic/$cort), [dawn protocol](/topic/dawn-protocol), [$bmy](/topic/$bmy), [$altr](/topic/$altr), [$anet](/topic/$anet), [$avav](/topic/$avav), [blake](/topic/blake), [goldman sachs](/topic/goldman-sachs), [$mlys](/topic/$mlys), [$irtc](/topic/$irtc), [$caci](/topic/$caci), [advanced micro devices](/topic/advanced-micro-devices), [$220b](/topic/$220b), [stocks utilities](/topic/stocks-utilities), [coins layer 1](/topic/coins-layer-1), [$cprx](/topic/$cprx), [trade desk inc](/topic/trade-desk-inc), [united therapeutics corp](/topic/united-therapeutics-corp), [$ewtx](/topic/$ewtx), [$insp](/topic/$insp), [$isrg](/topic/$isrg), [zach](/topic/zach), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$srpt](/topic/$srpt), [$arvn](/topic/$arvn), [$apls](/topic/$apls), [$bcax](/topic/$bcax), [$bhvn](/topic/$bhvn) ### Top Social Posts [#](/topic/$krys/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$KRYS -Bank of Ameruca raises Krystal Biotech target to $XXX from $XXX predicting peak Vyjuvek sales will exceed $X billion Buy -Guggenheim lifts target to $XXX from $XXX Buy -" [X Link](https://x.com/MarcJacksonLA/status/1979653550310588714) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-18T20:59Z 7581 followers, XXX engagements "$KRYS $XXXXXX Krystal Biotech skin gene therapy pricing sentiment cautious. 👍 🚀" [X Link](https://x.com/FameInDaMixxx/status/1979040359528214652) [@FameInDaMixxx](/creator/x/FameInDaMixxx) 2025-10-17T04:22Z XX followers, XX engagements "Health Care Weekly: Corcept Optime Sever Ties; FDA Adverse Event Reports on Compounded Semaglutide; Blumenthal Letter Targets AI in Medicare Advantage; CA Laws on PBMs Private Equity; New 483s h/t @AliceTrace67285 & @dorajfacundo $4568 $6472 $AMRX $CI $CORT $CVS $DSKYF $EHC $ERF.PA $GSK $HIMS $HROW $HUM $KRYS $LLY $LONN $LZAGY $MPLN $NOTV $NVO $OSCR $R $SNY $TEVA $TMO $UNH $VTRS" [X Link](https://x.com/Capitol_Forum/status/1978827222287827096) [@Capitol_Forum](/creator/x/Capitol_Forum) 2025-10-16T14:15Z 5982 followers, XXX engagements "Seven commercial in vivo gene therapies for rare diseases: Luxturna (RPE65-LCA2; $RRHBY) Zolgensma (SMA; $NVS) Kebilidi (AADC deficiency; $PTCT) Roctavian (HemA; $BMRN) Hemgenix (HemB; $QURE) and Elevidys (DMD; $SRPT) using AAV vectors and Vykuvek (DEB; $KRYS) using Herpesvirus. Zolgensma is a blockbuster ($1bn+ net sales/year). Elevidys was on-track to become one (strong demand) despite all the issues associated with systemic gene therapy. Luxturna has had strong demand but so few patients that the commercial case has been very challenging. Vyjuvek did $300M in revenues the first full-year" [X Link](https://x.com/GerardCaelles/status/1978550460983197811) [@GerardCaelles](/creator/x/GerardCaelles) 2025-10-15T19:56Z 1099 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Krystal Biotech receives FDA Platform Technology Designation, boosting confidence in its gene therapy platform. However, negative sentiment and price target cuts continue to weigh on the stock.
Krystal Biotech, Inc. Common Stock (KRYS) is a biotechnology company specializing in gene therapy for dermatological diseases.
Krystal Biotech, Inc. Common Stock uses the ticker $KRYS for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price is facing downward pressure due to negative sentiment and price target reductions, but a short-term positive trend suggests a possible price increase. The market is overall slightly positive, suggesting a hold on the stock.
24-Hour | 7-Day | 30-Day |
---|---|---|
XXXX% | XXX% | XXXX% |
1-Year High: $XXXXXX on 2024-11-08
1-Year Low: $XXXXXX on 2025-05-28
AltRank 24-Hour Time-Series Raw Data
Krystal Biotech, Inc. Common Stock (KRYS) is currently AltRank #878 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +446
1 Month: XXX +481
6 Months: XXX +406
1 Year: XXX +473
1-Year High: XXXXX on 2025-09-08
1-Year Low: XX on 2025-01-11
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX -XX
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2024-10-27
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-02-19
1-Year Low: XXX on 2025-10-19
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXX +92%
1-Year High: XXX on 2025-06-30
1-Year Low: XX on 2025-09-07
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Krystal Biotech, Inc. Common Stock (KRYS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +91%
1 Year: XXXXX +101%
1-Year High: XXX on 2025-06-30
1-Year Low: X on 2025-09-07
The most influential creators that mention Krystal Biotech, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@MarcJacksonLA | X | XXXXX | X | XXX |
@Andre_AGTC | X | XXXXX | X | XX |
@linhnguyen64143 | X | XX | X | X |
@seedy19tron | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-02-01
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XX | X% | XXX | XX% | X | X% |
Total | XX | X% | XXX | XX% | X | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% +0.0008999999999999998%
1 Month: XXXXXX% +0.0012%
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-11-04
1-Year Low: XXXXXX% on 2025-09-07
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-11-08
1-Year Low: XXXXXXX% on 2025-10-19
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$5.80%
1 Month: $XXXXXXXXXXXXX +$16%
6 Months: $XXXXXXXXXXXXX +$13%
1 Year: $XXXXXXXXXXXXX +$7%
1-Year High: $XXXXXXXXXXXXX on 2024-11-08
1-Year Low: $XXXXXXXXXXXXX on 2025-05-28
Top assets mentioned In the posts about Krystal Biotech, Inc. Common Stock in the last XX hours
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Ionis Pharmaceuticals, Inc. Common Stock (IONS) AAR Corp. (AIR) Century Aluminum Co (CENX) Celldex Therapeutics, Inc (CLDX) Astera Labs, Inc. Common Stock (ALAB) SoFi Technologies, Inc. Common Stock (SOFI) Tesla, Inc. (TSLA) AbbVie Inc (ABBV)
Top topics mentioned In the posts about Krystal Biotech, Inc. Common Stock in the last XX hours
stocks healthcare, sentiment, stocks technology, stocks basic materials, stocks financial services, stocks consumer cyclical, $mdgl, coins defi, pricing, $ions, stocks, $air, $cenx, $cldx, $alab, sofi technologies, coins solana ecosystem, tesla, $abbv, $xene, $bbio, coins bsc, henry, william, $halo, $insm, $inbs, $itci, $iti, $jspr, stocks consumer defensive, $brkb, $on, $nvts, stocks bitcoin treasuries, west pharmaceutical services inc, ge healthcare, $akro, $pcvx, $ptct, $mrus, $rytm, $vrna, $axsm, $dave, $mmyt, $abeo, $rares, $rvmd, $crsp, $beam, $celu, $clrb, $cadl, $spro, $apre, $pgy, $qnrx, $1b, 6 months, monaco, applied, deb, over the, confirms, vivo, $rrhby, $nvs, $bmrn, $amrx, $ci, $cort, dawn protocol, $bmy, $altr, $anet, $avav, blake, goldman sachs, $mlys, $irtc, $caci, advanced micro devices, $220b, stocks utilities, coins layer 1, $cprx, trade desk inc, united therapeutics corp, $ewtx, $insp, $isrg, zach, sarepta therapeutics inc, $srpt, $arvn, $apls, $bcax, $bhvn
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$KRYS -Bank of Ameruca raises Krystal Biotech target to $XXX from $XXX predicting peak Vyjuvek sales will exceed $X billion Buy -Guggenheim lifts target to $XXX from $XXX Buy -"
X Link @MarcJacksonLA 2025-10-18T20:59Z 7581 followers, XXX engagements
"$KRYS $XXXXXX Krystal Biotech skin gene therapy pricing sentiment cautious. 👍 🚀"
X Link @FameInDaMixxx 2025-10-17T04:22Z XX followers, XX engagements
"Health Care Weekly: Corcept Optime Sever Ties; FDA Adverse Event Reports on Compounded Semaglutide; Blumenthal Letter Targets AI in Medicare Advantage; CA Laws on PBMs Private Equity; New 483s h/t @AliceTrace67285 & @dorajfacundo $4568 $6472 $AMRX $CI $CORT $CVS $DSKYF $EHC $ERF.PA $GSK $HIMS $HROW $HUM $KRYS $LLY $LONN $LZAGY $MPLN $NOTV $NVO $OSCR $R $SNY $TEVA $TMO $UNH $VTRS"
X Link @Capitol_Forum 2025-10-16T14:15Z 5982 followers, XXX engagements
"Seven commercial in vivo gene therapies for rare diseases: Luxturna (RPE65-LCA2; $RRHBY) Zolgensma (SMA; $NVS) Kebilidi (AADC deficiency; $PTCT) Roctavian (HemA; $BMRN) Hemgenix (HemB; $QURE) and Elevidys (DMD; $SRPT) using AAV vectors and Vykuvek (DEB; $KRYS) using Herpesvirus. Zolgensma is a blockbuster ($1bn+ net sales/year). Elevidys was on-track to become one (strong demand) despite all the issues associated with systemic gene therapy. Luxturna has had strong demand but so few patients that the commercial case has been very challenging. Vyjuvek did $300M in revenues the first full-year"
X Link @GerardCaelles 2025-10-15T19:56Z 1099 followers, XXX engagements
/topic/$krys